The efficacy of medium-chain fatty acid oil diet
Not Applicable
Recruiting
- Conditions
- LC HCCiver cirrhosis, Hepatocellular carcinoma
- Registration Number
- JPRN-jRCT1031210329
- Lead Sponsor
- Sakaki Masashi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
1) Patients with liver cirrhosis or hepatocellular carcinoma who are visiting the Department of Gastroenterology, Showa University Hospital.
2) Patients with albumin 4.0 mg / dL or less.
3) Patients who are 20 years of age or older at the time of obtaining consent.
4) Patients who have given written consent to participate in this study.
Exclusion Criteria
1) Patients with uncontrolled hepatic encephalopathy.
2) Patients who require ascites puncture (twice or more a month).
3) Decompensated cirrhosis in patients with T-Bil of 3 or higher or in Child-Pugh classification grade C.
4) Patients who are judged to be ineligible by the judgment of the research doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of albumin level, prealbumin level, and retinol-binding protein by MCT diet
- Secondary Outcome Measures
Name Time Method Evaluation of liver function (Child-Pugh score, ALBI-grade)<br>Evaluation of amino acid balance (Fischer ratio)<br>Evaluation of lipid composition<br>Evaluation of muscle mass<br>Evaluation of body composition